Specifically, expression of the αVβ3 integrin in primary prostate tumors and metastatic lesions of mice carrying deletions of the PTEN (SKO), RB1 and PTEN (DKO) or RB1, PTEN, and TP53 (TKO) inversely correlates with αVβ6. Here, TP53 is linked to prostate neoplasm.